As of Dec 18, 2024, Esperite's P/S ratio stood at 0.79, a 23.44% change from the 0.64 P/S ratio recorded in the previous year.

The Esperite P/S history

Esperite Aktienanalyse

What does Esperite do?

Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Esperite's P/S Ratio

Esperite's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Esperite's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Esperite's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Esperite’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Esperite stock

What is the price-to-earnings ratio of Esperite?

The price-earnings ratio of Esperite is currently 0.79.

How has the price-earnings ratio of Esperite changed compared to last year?

The price-to-earnings ratio of Esperite has increased by 23.44% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Esperite high compared to other companies?

Yes, the price-to-earnings ratio of Esperite is high compared to other companies.

How does an increase in the price-earnings ratio of Esperite affect the company?

An increase in the price-earnings ratio of Esperite would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Esperite affect the company?

A decrease in the price-earnings ratio of Esperite would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Esperite?

Some factors that influence the price-earnings ratio of Esperite are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Esperite pay?

Over the past 12 months, Esperite paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Esperite is expected to pay a dividend of 0 EUR.

What is the dividend yield of Esperite?

The current dividend yield of Esperite is .

When does Esperite pay dividends?

Esperite pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Esperite?

Esperite paid dividends every year for the past 0 years.

What is the dividend of Esperite?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Esperite located?

Esperite is assigned to the 'Health' sector.

Wann musste ich die Aktien von Esperite kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Esperite from 6/14/2012 amounting to 0.08 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2012.

When did Esperite pay the last dividend?

The last dividend was paid out on 6/14/2012.

What was the dividend of Esperite in the year 2023?

In the year 2023, Esperite distributed 0 EUR as dividends.

In which currency does Esperite pay out the dividend?

The dividends of Esperite are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Esperite

Our stock analysis for Esperite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Esperite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.